Tellus BioVentures

All News

Viridian Announces Positive Initial Clinical Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease

Aug 15, 2022

Penn Spinout Vittoria Biotherapeutics Emerges from Stealth Mode with $10M Seed Round

Jun 07, 2022

Dianthus Therapeutics Launches with $100M to Develop Selective Antibody Complement Therapeutics to Treat Severe and Rare Autoimmune Diseases

May 03, 2022

Interius BioTherapeutics Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform

Dec 09, 2021

Navrogen Closes $3.0M Seed Financing To Advance Its Preclinical Pipeline Targeting Humoral Immunosuppressed Cancers And Immune-Related Disorders

Aug 09, 2021

Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform

May 18, 2021

Two M&A deals and $9B later, Lonnie Moulder is ramping up his latest biotech startup. And this one comes with global vision built in.

Mar 23, 2021

MiRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments

Jan 19, 2021

MiRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.

Oct 28, 2020

FDA Grants Fast Track Status to Aegle Therapeutics’ AGLE-102 for the Treatment of Dystrophic Epidermolysis Bullosa

Oct 01, 2020

Aegle Therapeutics Completes $6.5M Series A Financing

Sep 29, 2020

Latest Penn biotech spinout taking on cancer raises $1.6M from investors

Mar 31, 2020

Zai Lab Appoints Lonnie Moulder to Board of Directors

Jan 14, 2020

Helsinn appoints Eric Cornut and Lonnie Moulder to the Board of Directors

Jan 13, 2020

Aegle Therapeutics Announces $4M Financing to Fund Groundbreaking Stem Cell Exosome Clinical Trial to Treat Orphan Disease Dystrophic Epidermolysis Bullosa

Jan 07, 2020